Literature DB >> 2822753

Studies on the attenuation of the Sabin type 3 oral polio vaccine.

J W Almond1, G D Westrop, D M Evans, G Dunn, P D Minor, D Magrath, G C Schild.   

Abstract

The genetic basis of attenuation of the poliovirus type 3 vaccine strain P3/Leon 12a1b has been investigated by comparing the nucleotide sequence of this strain with that of its neurovirulent progenitor P3/Leon/37 and by constructing recombinants between these two viruses using infectious cDNAs. Preliminary results suggest that attenuation is caused by just two point mutations, one occurring in the 5' non-coding region and the other causing an amino acid change in coat protein VP3.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2822753     DOI: 10.1016/0166-0934(87)90081-4

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  5 in total

1.  Mapping of mutations associated with neurovirulence in monkeys infected with Sabin 1 poliovirus revertants selected at high temperature.

Authors:  C Christodoulou; F Colbere-Garapin; A Macadam; L F Taffs; S Marsden; P Minor; F Horaud
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

2.  Attenuation and cell culture adaptation of hepatitis A virus (HAV): a genetic analysis with HAV cDNA.

Authors:  J I Cohen; B Rosenblum; S M Feinstone; J Ticehurst; R H Purcell
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

3.  Genetic basis for immunological aberrations in poliovirus Sabin serotype 3 strains imported in the netherlands.

Authors:  J H Reimerink; H G van der Avoort; A M van Loon; M P Koopmans
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

4.  Correlation between poliovirus type 1 Mahoney replication in blood cells and neurovirulence.

Authors:  M S Freistadt; K E Eberle
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

5.  Coxsackievirus B3 from an infectious cDNA copy of the genome is cardiovirulent in mice.

Authors:  S Tracy; N M Chapman; Z Tu
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.